Drew McManus on the Orchestra business | est. 2003

Uncategorized

Concert Companion or ORBIT Part 2

Tue, Oct 10, 2004
Continuing from where things left off in Part 1, this installment will examine the new Concert Companion and ORBIT products in further detail.  Both products are technology based solutions designed to help develop a new audience for live orchestral classical music.  The Concert Companion is a proprietary palm driven device and ORBIT is a web

Reader Response: Concert Companion or ORBIT

Mon, Oct 10, 2004
After publishing Concert Companion or ORBIT Part 1 I received an email from Andrew Yarosh, Madison Symphony Orchestra’s Development Director.  He was looking at the situation from a small orchestra point of view and that of a patron: It seems these tools are, in the best of all possible worlds (i.e. when all orchestras have

National Arts Journalism Program

Sun, Oct 10, 2004
The idea behind long term planning requires an organization to look at their past, examine their present, and visualize their future. But what if your organization isn’t a single entity such as an orchestra?  Is it possible for a loose confederation of individuals with a common tie to engage in long term planning? The Music

Saving Or Selling Out Their Future In Baltimore?

Wed, Sep 9, 2004
Last Sunday, the Baltimore Sun published an article by Paul Adams and Tim Smith which reports that in order to manage their planned $12 million deficit, the Baltimore Symphony is considering selling their performance venue; Meyerhoff Symphony Hall. According to the Sun article, here are the details for the plan: “Under the scenario presented, [a]

Sex, Drugs, And Classical Music?

Mon, Sep 9, 2004
A few weeks ago I published an article at The Partial Observer about some of the ways classical music uses sex to sell itself.  This week I’m following up on that idea by discussing the growing drug use debate (no, not that kind of drug use). The article, Performance Enhancing Drugs for Musicians?, will be
Previous Next